Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results
03 avr. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024, after the...
Accolade To Present at Upcoming Investor Conferences
28 févr. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: Raymond James 45th Annual...
Accolade Announces Results for Fiscal Third Quarter 2024
08 janv. 2024 16h03 HE
|
Accolade, Inc.
SEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. “As we head into the new year,...
Accolade To Present at Upcoming Investor Conferences
02 janv. 2024 08h00 HE
|
Accolade, Inc.
SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: 42nd Annual J.P. Morgan...
Accolade to Announce Fiscal Third Quarter 2024 Financial Results
11 déc. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2024 financial results on Monday, January 8, 2024, after the market...
Accolade To Present at Piper Sandler 35th Annual Healthcare Conference
27 nov. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th...
Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026
16 nov. 2023 16h03 HE
|
Accolade, Inc.
SEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it has entered into separate, privately negotiated transactions with certain holders of its outstanding...
Accolade To Present at Stephens Annual Investment Conference
08 nov. 2023 15h00 HE
|
Accolade, Inc.
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stephens Annual...
Accolade Announces Results for Fiscal Second Quarter 2024
04 oct. 2023 16h05 HE
|
Accolade, Inc.
SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. “We are halfway through the 2024...
Accolade to Announce Fiscal Second Quarter 2024 Financial Results
20 sept. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024...